Clinical Trial Results:
ESTUDIO EN FASE III, MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO Y OXICODONA PARA DETERMINAR LA EFICACIA Y LA SEGURIDAD DE TANEZUMAB EN PACIENTES CON ARTROSIS DE RODILLA O CADERA
A Phase 3 Randomized, Double-Blind, Placebo- and Oxycodone-Controlled, Multicenter Study of the Efficacy and Safety of Tanezumab in Patients with Osteoarthritis of the Knee or Hip
Summary
|
|
EudraCT number |
2009-013329-41 |
Trial protocol |
ES SE DE AT DK FR |
Global completion date |
04 Feb 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
26 Aug 2016
|
First version publication date |
26 Aug 2016
|
Other versions |
|
Summary report(s) |
A4091030 Public Disclosure Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.